You are using an unsupported browser.
Some features of this site may not function properly. For optimal user experience, please view this site in Chrome, Firefox, Safari, or Edge.
The first and only FDA-cleared molecular Trichomonas vaginalis test for both women and men
Ordering Info
Molecular Diagnostics Offers New Approach for Managing STDs. ZDoggMD and Cepheid CMO Dave Persing talk about sex. They dive into the topic head-on to talk about sexual health clinics, the STD epidemic and changing the face of STDs through advances in technology.
According to the Centers for Disease Control and Prevention (CDC), Trichomonas vaginalis (TV) is the most prevalent nonviral sexually transmitted infection in the United States, affecting an estimated 2.3M women and 1.4M men.1,2
TV is associated with:
(1) Workowski KA, Bolan G. CDC. Sexually Transmitted Diseases Treatment Guidelines, 2015. MMWR Recomm Rep 2015;64(No.3):72.;
(2) Meites El, et al. A Review of Evidence-Based Care of Symptomatic Trichomoniasis and Asymptomatic Trichomonas vaginalis Infections. Clin Infect Dis. 2015 Dec 15;61 Suppl 8:S837-48.
Xpert TV is the only FDA-cleared NAAT test for Trichomonas vaginalis testing in female and male specimens. Xpert TV supports same-day patient consultation and treatment by physicians.
On-demand TV testing — a next generation solution:
* With EAT (Early Assay Termination), for positive results.
* With EAT (Early Assay Termination), for positive results.
Number of Tests: 10
Catalog #: GXTV-10
